Retatrutide is a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By stimulating these receptors, https://aprilutha468771.blogzet.com/setmelanotide-a-promising-new-treatment-for-obesity-50991257